Ublituximab, also known as LFB-R603, TG-1101, and TGTX-1101, represents a next-generation, type 1 chimeric monoclonal antibody designed to selectively bind to a unique epitope on the CD20 antigen. This targeting facilitates the induction of cytotoxic effects against CD20-expressing B cells, commonly implicated in various hematological malignancies. Ublituximab's mechanism of action and specificity make it a valuable tool in the research and treatment of cancer.
Ublituximab, also known as LFB-R603, TG-1101, and TGTX-1101, represents a next-generation, type 1 chimeric monoclonal antibody designed to selectively bind to a unique epitope on the CD20 antigen. This targeting facilitates the induction of cytotoxic effects against CD20-expressing B cells, commonly implicated in various hematological malignancies. Ublituximab's mechanism of action and specificity make it a valuable tool in the research and treatment of cancer.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
